NCT06992609
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06992609
Title Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. (ALBORAN)
Acronym ALBORAN
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Research Site RECRUITING A Coruña 15006 Spain Details
Research Site RECRUITING Badajoz 06080 Spain Details
Research Site RECRUITING Barakaldo 48903 Spain Details
Research Site RECRUITING Barcelona 08035 Spain Details
Research Site RECRUITING Barcelona 08036 Spain Details
Research Site NOT_YET_RECRUITING Barcelona 08907 Spain Details
Research Site RECRUITING Jerez de la Frontera 11407 Spain Details
Research Site RECRUITING Madrid 28041 Spain Details
Research Site RECRUITING Madrid 28046 Spain Details
Research Site RECRUITING Málaga 29010 Spain Details
Research Site NOT_YET_RECRUITING Oviedo 33011 Spain Details
Research Site NOT_YET_RECRUITING Santander 39008 Spain Details
Research Site RECRUITING Seville 41013 Spain Details
Research Site RECRUITING Valencia 46026 Spain Details
Research Site RECRUITING Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field